Company ATON Deutsche Boerse AG

Stocks

3HB

FR0004153930

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG 10:34:38 2026-09-11 EDT			5-day change	1st Jan Change
0.0140 ^EUR	+32.08%		+25.00%	+438.46%

04-30	Aton Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-29	Aton Auditor Raises 'Going Concern' Doubt	CI

Business description: ATON

ATON is a medical science group committed to the future of medicine, with the aim of improving patient care and the safety and efficacy of treatments. ATON guides and develops a portfolio of cutting-edge companies, each with its own specialty, working in synergy to advance the medicine of today and tomorrow.

Sales by Activity: ATON

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	-	1.56K	382K	614K	661K

See all business segments

Executive Committee: ATON

Manager	Title	Age	Since
Ayikoélé Léone Atayi CEO	Chief Executive Officer	-	2022-01-05
Hadrien Lanvin PRN	Corporate Officer/Principal	-	2026-02-17

See ATON governance

Composition of the Board of Directors: ATON

Director	Title	Age	Since
Ayikoélé Léone Atayi CHM	Chairman	-	2023-12-19
Pierre Eftekhari BRD	Director/Board Member	-	2021-09-20
Virginie Miath BRD	Director/Board Member	-	2023-12-19
Elie Fraenckel BRD	Director/Board Member	-	2023-12-19
Enrico Jose Adolfo Bastianelli BRD	Director/Board Member	-	2023-12-19
Hadrien Lanvin BRD	Director/Board Member	-	2023-12-19